Navigation Links
Generex Touts Pipeline Potential of Antigen Express Subsidiary
Date:2/7/2013

esults to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis Corp., ... independent members to its Board of Directors, enhancing ... of the company, a leading licensed producer of ... Internationally, Bedrocan has 13 years, experience in producing ... seven countries, including Canada. As ...
(Date:8/21/2014)... Aug. 21, 2014   Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced positive results from a ... histolyticum (or CCH) for the treatment of edematous ... the Phase 2a trial, all three doses of ... showed an improvement in the appearance of cellulite ...
(Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down methamphetamine offenders and make arrests. Data released ... Missouri blocked the sale of more ...
Breaking Medicine Technology:Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... June 22, 2011 CardioGenics Holdings Inc. (CGNH.OB) ... business unit, which develops ultra sensitive magnetic beads ... subsidiary, Luxspheres Inc. The beads business unit, which ... Inc. Canadian subsidiary ("CardioGenics"), will now be operated ...
... Lighting has developed, tested, and confirmed by independent testing ... bare or gloved hands safely and quickly, achieves -6log10 ... difficile spores. It has developed a simple, proprietary ... of gloved or bare hands is implemented within a ...
Cached Medicine Technology:CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary 2CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary 3Germgard Lighting Demonstrates Two-Second, Bare and Gloved Hand Sterilization 2Germgard Lighting Demonstrates Two-Second, Bare and Gloved Hand Sterilization 3
(Date:8/21/2014)... HOUSTON (Aug. 21, 2014) An international scientific ... clues about genetic alterations that may contribute to a ... only into this rare cancer but other types as ... Institutes of Health,s Cancer Genome Atlas initiative , ... published the results today in the journal Cancer ...
(Date:8/21/2014)... 21, 2014Popular fiction that normalizes and glamorizes violence against ... be associated with a greater risk of potentially harmful ... new study are presented in the article " Fiction ... in Adolescent and Young Adult Females ," published in ... from Mary Ann Liebert, Inc., publishers . The ...
(Date:8/21/2014)... N.C. August, 21, 2014 Young girls with ... organs may be at increased risk of developing urinary ... Forest Baptist Medical Center. The treatment may be as ... as bubble baths and swimming pools. , "Vulvitis is ... ages," said senior author Steve J. Hodges, M.D., associate ...
(Date:8/21/2014)... NY (PRWEB) August 21, 2014 The ... patient survey tool called RateMyHospital®, which captures real-time patient ... improve each patient’s care. The tool, now available to ... oncology units, collects feedback regarding patient satisfaction using smartphones. ... survey tool, because it gives us the timely information ...
(Date:8/21/2014)... August 21, 2014 Entries are now ... the only comprehensive national awards program totally dedicated to ... development and executive leadership. The entry deadline is Oct. ... Real Estate Insights™, the first and only national magazine ... and investment. , “We launched the HREI Insights Awards ...
Breaking Medicine News(10 mins):Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 3Health News:Women's health and Fifty Shades: Increased risks for young adult readers? 2Health News:Researchers identify potential risk factors for urinary tract infections in young girls 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 3Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4
... , , MONDAY, March 3 (HealthDay News) -- Parents may not ... a good idea to just have that one big "sex ... you encourage an ongoing dialogue about sex with your children ... kids are less likely to engage in risky sexual behaviors. ...
... Suracell Italy; other ... SOUTH ORANGE, N.J., March 3 Suracell, Inc.,( ... age management programs, announces the launch of the ... its cutting edge programs to,the international audience. DNA ...
... Popovits to be Honored at Gala Dinner in San Francisco ... Calif., Mar. 3 Women,Health Care Executives of Northern California ... of Redwood,City-based Genomic Health, Inc., has been named its 2008 ... dinner to be held at the,Carnelian Room atop the Bank ...
... Access to Local Community, SUNNYVALE, Calif., March ... global leader in the field of radiosurgery,announced today ... second,CyberKnife(R) Robotic Radiosurgery System for its western satellite,location ... will allow those,living in the rural communities easier ...
... Files application to list shares on American Stock ... China Sky One,Medical, Inc. (OTC Bulletin Board: CSKI; ... distributor of pharmaceutical, medicinal and,diagnostic products in China, ... to its board -- including Song Chun Fang, ...
... Uroplasty, Inc. (Amex:,UPI) announced today the ... on,its Urgent(R) PC Neuromodulation System, a proprietary, ... treatment of overactive,bladder (OAB) symptoms, at the ... Symposium in Tampa, Florida. These retrospective and,observational ...
Cached Medicine News:Health News:That 'Sex Talk' With Your Kids Should Be Ongoing 2Health News:That 'Sex Talk' With Your Kids Should Be Ongoing 3Health News:Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally 2Health News:Women Health Care Executives Names Genomic Health President Kimberly Popovits as 'Woman of the Year' 2Health News:St. Louis University Hospital Purchases Second CyberKnife(R) System 2Health News:St. Louis University Hospital Purchases Second CyberKnife(R) System 3Health News:China Sky One Medical, Inc. Appoints Four Independent Board Members 2Health News:China Sky One Medical, Inc. Appoints Four Independent Board Members 3Health News:China Sky One Medical, Inc. Appoints Four Independent Board Members 4Health News:Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium 2Health News:Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: